GSH plays the role of master antioxidant in tissues
CrossRef A Narrative Review on the Risk Factors and Healthcare Disparities of Type 2 Diabetes Elvira Meni Maria Gkrinia, Andrej Belani Diabetology .2025
42,43 Several GLP-1R agonists, including exenatide, liraglutide, and semaglutide, have been used in NASH clinical research
Weeks 14: The Adjustment Phase Most patients start noticing appetite changes within the first one to two weeks
Progression risk: NAFLD can progress to NASH (with inflammation), fibrosis, cirrhosis, and liver failure
It has an effect on both GLP-1 and GIP which is known to have a synergistic effect on the GLP1 action which can potentially deliver better or improved weight loss results than Ozempic